Microsatellite Instability in Colorectal Cancer

Boland, C. Richard, Goel, Ajay·2010·Gastroenterology
DOI 10.1053/j.gastro.2009.12.064

Cited by (1,002)

Items 901–1,000 of 1,002

  1. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients
    Pan Li, Zhitao Xiao, Todd A. Braciak, Qingjian Ou, Gong Chen, Fuat S. Oduncu · 2017 · PLoS ONE
  2. The association of low penetrance genetic risk modifiers with colorectal cancer in lynch syndrome patients: a systematic review and meta-analysis
    Neil Donald, Salim S. Malik, Joshua L. McGuire, Kevin John Monahan · 2017 · Familial Cancer
  3. Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth
    Tatjana Pandzic, Verónica Rendo, Jinyeong Lim, Chatarina Larsson, Jimmy Larsson, Ivaylo Stoimenov, Snehangshu Kundu, Muhammad Akhtar Ali, Mats Hellström, Liqun He et al. · 2017 · Oncotarget
  4. The MDR1/ABCB1 gene rs 1045642 polymorphism in colorectal cancer
    Beata Mrozikiewicz‐Rakowska, Marian Malinowski, Piotr Nehring, Joanna Bartkowiak-Wieczorek, Anna Bogacz, Ewa Żurawińska-Grzelka, Przemysław Krasnodębski, J Muszyński, Tomasz Grzela, Adam M. Przybyłkowski et al. · 2017 · Archives of Medical Science
  5. Mismatch Repair Deficiency Assessment by Immunohistochemistry: For Lynch Syndrome Screening and Beyond
    Hui‐Li Wong, Michael Christie, Lucy Gately, Jeanne Tie, Belinda Lee, Christine Semira, Sheau Wen Lok, Rachel Wong, Peter Gibbs · 2018 · Future Oncology
  6. Proximal shift of colorectal cancer with increasing age in different ethnicities
    Lin Yang, Zhenchong Xiong, Wenzhuo He, Kunqian xie, Shousheng Liu, Pengfei Kong, Chang Jiang, Guifang Guo, Liangping Xia · 2018 · Cancer Management and Research
  7. Association of genetic ancestry with colorectal tumor location in Puerto Rican Latinos
    Julyann Pérez-Mayoral, Marievelisse Soto-Salgado, Ebony Shah, R. Kittles, M. Stern, Myrta I. Olivera, M. González-Pons, Segundo Rodriguez-Quilichinni, Marla Torres, José S. Reyes et al. · 2019 · Human Genomics
  8. Immune landscape and biomarkers for immuno-oncology in colorectal cancers
    Jeong Mo Bae, Seung-Yeon Yoo, Jung Ho Kim, Gyeong Hoon Kang · 2020 · Journal of Pathology and Translational Medicine
  9. Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer
    Kjersti Elvestad Hestetun, Kristine Aasebø, Benedikte Rosenlund, Yvonne M. F. Muller, Olav Dahl, Mette Pernille Myklebust · 2020 · Modern Pathology
  10. KRAS mutations are negatively correlated with immunity in colon cancer
    Xiaorui Fu, Xinyi Wang, Jinzhong Duanmu, Taiyuan Li, Qunguang Jiang · 2020 · Aging
  11. CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer
    Chia‐Lo Chang, Chi‐Ruei Huang, Shu‐Jyuan Chang, Chun‐Chieh Wu, Hong‐Hwa Chen, Chi‐Wen Luo, Hon‐Kan Yip · 2021 · International Journal of Biological Sciences
  12. Impact of the ileal microbiota on colon cancer
    María Paula Roberti, Conrad Rauber, Guido Kroemer, Laurence Zitvogel · 2021 · Seminars in Cancer Biology
  13. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer
    Leonel Pekarek, Oscar Fraile‐Μartinez, Cielo García Montero, Miguel A. Sáez, Ines Barquero-Pozanco, Laura del Hierro-Marlasca, Patricia De Castro-Martinez, Adoración Romero-Bazán, Miguel Ángel Álvarez-Mon, Jorge Monserrat et al. · 2022 · Cancers
  14. Molecular Markers Predictive of Chemotherapy Response in Colorectal Cancer
    Stacey Shiovitz, William M. Grady · 2015 · Current Gastroenterology Reports
  15. Familial gastric cancer: update for practice management
    Giovanni Corso, Daniele Marrelli, Franco Roviello · 2010 · Familial Cancer
  16. Clinical and prognosis value of the CIMP status combined with MLH1 or p16 INK4a methylation in colorectal cancer
    Amana Saadallah-Kallel, Rania Abdelmaksoud‐Dammak, Mouna Triki, Slim Charfi, Abdelmajid Khabir, Tahia Sallemi-Boudawara, Raja Mokdad‐Gargouri · 2017 · Medical Oncology
  17. Prognostic significance of microsatellite instability‑associated pathways and genes in gastric cancer
    Xiaosheng Hang, Dapeng Li, Jianping Wang, Ge Wang · 2018 · International Journal of Molecular Medicine
  18. A review on role of ATM gene in hereditary transfer of colorectal cancer.
    Sushmitha Sriramulu, Murugesan Ramachandran, Saraswathi Subramanian, Rathiusha Kannan, Madhumala Gopinath, Jose Decena Sollano, Laura Bissi, Antara Banerjee, Francesco Marotta, Surajit Pathak · 2019 · Acta bio-medica dell'Ateneo parmense/Acta biomedica
  19. Challenges and opportunities for precision medicine in developing nations
    Juan‐Manuel Anaya, María Herrán, Luis Eduardo Pino · 2025 · Expert Review of Precision Medicine and Drug Development
  20. Colon cancer microsatellite instability influences computed tomography assessment of regional lymph node morphology and diagnostic performance
    Young Tae Kim, Ji Hye Min, Kyue-Hee Choi, Honsoul Kim · 2022 · European Journal of Radiology
  21. Predicting Mismatch‐Repair Status in Rectal Cancer Using Multiparametric MRI‐Based Radiomics Models: A Preliminary Study
    Guodong Jing, Yukun Chen, Xiaolu Ma, Zhihui Li, Haidi Lu, Yuwei Xia, Yong Lü, Jianping Lu, Fu Shen · 2022 · BioMed Research International
  22. Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer
    Xingwu Liu, Guanyu Yan, Boyang Xu, Han Yu, Yue An, Mingjun Sun · 2022 · Frontiers in Immunology
  23. CT-based deep learning model for the prediction of DNA mismatch repair deficient colorectal cancer: a diagnostic study
    Wuteng Cao, Huabin Hu, Jirui Guo, Qiyuan Qin, Yanbang Lian, Jiao Li, Qianyu Wu, Junhong Chen, Xinhua Wang, Yanhong Deng · 2023 · Journal of Translational Medicine
  24. Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment
    Faranak Alipourgivi, Aishat Motolani, Ai-Hua Qiu, Wenan Qiang, Guang‐Yu Yang, Shuibing Chen, Tao Lu · 2023 · International Journal of Molecular Sciences
  25. Detecting microsatellite instability in colorectal cancer using Transformer-based colonoscopy image classification and retrieval
    Chung‐Ming Lo, Jeng‐Kai Jiang, Chun‐Chi Lin · 2024 · PLoS ONE
  26. Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee
    Anne Monette, Sarah Warren, J. Carl Barrett, Charlie Garnett‐Benson, Kurt Alex Schalper, Janis Marie Taube, Brian Gregory Topp, Alexandra Snyder · 2024 · Journal for ImmunoTherapy of Cancer
  27. Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics
    Holly R. Pinkney, Cody R. Ross, Timothy Oliver Hodgson, Sharon Tracy Pattison, Sarah D. Diermeier · 2024 · npj Precision Oncology
  28. Mucosal immune environment in colonic carcinogenesis: CD80 expression is associated to oxidative DNA damage and TLR4–NFκB signalling
    Marco Scarpa, Romilda Cardin, Marina Bortolami, Andromachi Kotsafti, Maria Cristina Scarpa, Anna Pozza, Giorgia Maran, Marika Piciocchi, Cesare Ruffolo, Renata D'Incà et al. · 2012 · European Journal of Cancer
  29. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome
    Meghan Rose Flanagan · 2015 · World Journal of Gastroenterology
  30. Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer
    Andrea J. Savio, Bharati V. Bapat · 2017 · Epigenetics
  31. Genome-wide DNA methylation differences according to oestrogen receptor beta status in colorectal cancer
    Sonja Neumeyer, Odilia Popanda, Dominic Edelmann, Katja Butterbach, Csaba Tóth, Wilfried Roth, Hendrik Bläker, Ruijingfang Jiang, Esther Herpel, Cornelia Jäkel et al. · 2019 · Epigenetics
  32. Sugary Drink Consumption and Subsequent Colorectal Cancer Risk: The Japan Public Health Center–Based Prospective Cohort Study
    Chi Yan Leung, Sarah Krull Abe, Norie Sawada, Junko Ishihara, Ribeka Takachi, Taiki Yamaji, Motoki Iwasaki, Masahiro Hashizume, Manami Inoue, Shoichiro Tsugane · 2021 · Cancer Epidemiology Biomarkers & Prevention
  33. Gastrointestinal Microbiota Dysbiosis Associated with SARS-CoV-2 Infection in Colorectal Cancer: The Implication of Probiotics
    Frederick Odun-Ayo, Lalini Reddy · 2022 · Gastroenterology Insights
  34. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer
    Junli Ma, Yan Zhang, Hong Shen, Linda Kapesa, Wenqiang Liu, Mengsi Zeng, Shan Zeng · 2015 · Tumor Biology
  35. Competing risks analysis of microsatellite instability as a prognostic factor in colorectal cancer
    J Toh, Pierre H. Chapuis, Les Bokey, Charles Chan, Kevin J. Spring, Owen F. Dent · 2017 · British journal of surgery
  36. Evaluation of a Fully Automated Idylla Test System for Microsatellite Instability in Colorectal Cancer
    Xiang Li, Jin Xu, Lei Li, Xiaofeng Mu, Ye Wang, Xinmin Li · 2019 · Clinical Colorectal Cancer
  37. Precision Approaches in the Management of Colorectal Cancer: Current Evidence and Latest Advancements towards Individualizing the Treatment
    Rebecca A. Shuford, Ashley Cairns, Omeed Moaven · 2020 · Cancers
  38. Microbial manipulators: Fusobacterium nucleatum modulates the tumor immune microenvironment in colorectal cancer
    Qian Li, Wanyi Luo, Xiao Li, Xin Xu, Xian Peng, Lei Cheng, Xuedong Zhou, Xin Min Zheng · 2025 · Journal of Oral Microbiology
  39. Lymphocyte micronuclei frequencies in skin, haematological, prostate, colorectal and esophageal cancer cases: A systematic review and meta-analysis
    Varinderpal Singh Dhillon, Permal Deo, Stefano Bonassi, Michael Felix Fenech · 2021 · Mutation Research/Reviews in Mutation Research
  40. Defects in MMR Genes as a Seminal Example of Personalized Medicine: From Diagnosis to Therapy
    Arianna Dal Buono, Federica Gaiani, Laura Poliani, Carmen Correale, Luigi Laghi · 2021 · Journal of Personalized Medicine
  41. Comprehensive Analysis of the Prognostic and Immunological Role of PAFAH1B in Pan-Cancer
    Yixiao Yuan, Xiulin Jiang, Lin Tang, Juan Wang, Lincan Duan · 2022 · Frontiers in Molecular Biosciences
  42. Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
    Laura Grumetti, Rita Lombardi, Federica Iannelli, Biagio Pucci, Antonio Avallone, Elena Di Gennaro, Alfredo Budillon · 2022 · Cancers
  43. The emerging era of personalized medicine in advanced colorectal cancer
    Claudia Wing‐Kwan Wu, Madeleine Reid, Simon John Leedham, Rashid Nok-Shun Lui · 2022 · Journal of Gastroenterology and Hepatology
  44. Isothiocyanate-Rich Extracts from Cauliflower (Brassica oleracea Var. Botrytis) and Radish (Raphanus sativus) Inhibited Metabolic Activity and Induced ROS in Selected Human HCT116 and HT-29 Colorectal Cancer Cells
    Mardey Liceth Cuéllar-Núñez, Iván Luzardo‐Ocampo, Sarah N Lee-Martínez, Michelle Larrauri-Rodríguez, Guadalupe Zaldívar‐Lelo de Larrea, Rosa Martha Pérez‐Serrano, Nicolás Camacho-Calderón · 2022 · International Journal of Environmental Research and Public Health
  45. Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
    Sheefa Mirza, Kinjal P. Bhadresha, Muhammad Jameel, Michelle McCabe, Reza Shahbazi, Paul Ruff, Clement Brian Penny · 2023 · Frontiers in Oncology
  46. Urachal carcinoma: The journey so far and the road ahead
    Rajesh Kumar, Seetha Harilal, Mohamed Abdelwahab Abdelgawad, Mohammed M. Ghoneim, Arun J. Kumar, Bijo Mathew · 2023 · Pathology - Research and Practice
  47. The genomics of sporadic and hereditary colorectal cancer
    Iannish D. Sadien, RJ Davies, J. M. D. Wheeler · 2024 · Annals of The Royal College of Surgeons of England
  48. PROTAC-mediated conditional degradation of the WRN helicase as a potential strategy for selective killing of cancer cells with microsatellite instability
    Vikram Tejwani, Thomas D. Carroll, Thomas Macartney, Susanne Bandau, Constance Alabert, Giulia Saredi, Rachel L. Toth, John Wilson Rouse · 2024 · Scientific Reports
  49. Characterization of a New Small Bowel Adenocarcinoma Cell Line and Screening of Anti-Cancer Drug against Small Bowel Adenocarcinoma
    Hirobumi Suzuki, Yoshihiro Hirata, Nobumi Suzuki, Sozaburo Ihara, Kosuke Sakitani, Yuka Kobayashi, Hiroto Kinoshita, Yoku Hayakawa, Atsuo Yamada, Hirotsugu Watabe et al. · 2014 · American Journal Of Pathology
  50. DNA Repair Gene - XRCC1 in Relation to Genome Instability and Role in Colorectal Carcinogenesis
    Saniya Nissar, Syed Sameer Aga, Roohi Rasool, Fouzia Rashid · 2014 · Oncology Research and Treatment
  51. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome
    Miguel Serrano, Pedro Lage, Sara Belga, Bruno Filipe, Inês Francisco, Paula Rodrigues, Ricardo Fonseca, Paula P. Chaves, Isabel Claro, Cristina M Albuquerque et al. · 2012 · Familial Cancer
  52. Novel biomarkers for the prediction of metastasis in colorectal cancer
    Inti Zlobec · 2012 · Expert Opinion on Medical Diagnostics
  53. Genito-urinary genomics and emerging biomarkers for immunomodulatory cancer treatment
    Thomas Gevaert, Rodolfo Montironi, Antonio Lopez-beltran B, Geert van Leenders, Yves Allory, Dirk J. M. K. De Ridder, Frank Claessens, Mark M. Kockx, Murat Akand, Steven Joniau et al. · 2017 · Seminars in Cancer Biology
  54. Identification of PMN-released mutagenic factors in a co-culture model for colitis-associated cancer
    Nicolas Granofszky, Michaela Lang, Vineeta Khare, Gerald Schmid, Theresa Scharl, Franziska Ferk, Kristine Jimenez, Siegfried Knasmüller, Christoph Campregher, Christoph Gasché · 2017 · Carcinogenesis
  55. Somatic mutation driven codon transition bias in human cancer
    Hyeonju Son, Hyundeok Kang, Hyun Seok Kim, Sangwoo Kim · 2017 · Scientific Reports
  56. Evaluation genotypes of cancer cell lines HCC1954 and SiHa by short tandem repeat (STR) analysis and DNA sequencing
    Jiewen Fu, Jingliang Cheng, Jun Li, Jun Li, Chunli Wei, Xiaoli Zheng, Tao He, Junjiang Fu · 2018 · Molecular Biology Reports
  57. IL‐17R deletion predicts high‐grade colorectal cancer and poor clinical outcomes
    Chi Wing Yan, Weei‐Yuan Huang, Jeanette E. Boudreau, Animamalar Mayavannan, Zhenyu Cheng, Jun Wang · 2019 · International Journal of Cancer
  58. Drug resistance in cancer immunotherapy: new strategies to improve checkpoint inhibitor therapies
    Jesús Rodríguez-Pascual, Ángel Ayuso‐Sacido, Cristóbal Belda-Iniesta · 2019 · Cancer Drug Resistance
  59. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability
    Holly Russell, Katarzyna Kedzierska, Daniel D. Buchanan, Rachael J. Thomas, Emma Tham, Miriam Mints, Anne Keränen, Graham G. Giles, Melissa C. Southey, Roger Laughlin Milne et al. · 2020 · Clinical Epigenetics
  60. Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer
    Zhenghao Cai, Weiwei Rui, Shuchun Li, Abe L. Fingerhut, Jing Sun, Junjun Ma, Lu Zang, Zhenggang Zhu, Minhua Zheng · 2020 · Frontiers in Oncology
  61. Diagnostic and therapeutic biomarkers in colorectal cancer: a review.
    Jéssica Vieira de Assis, Lucélia Antunes Coutinho, Ifeoluwa Temitayo Oyeyemi, Oyetunde Timothy Oyeyemi, Rafaella Fortini Queiroz Grenfell · 2022 · PubMed Central
  62. Microsatellite instability and chemosensitivity in solid tumours
    Sara Cherri, Ester Oneda, Silvia Noventa, Laura Melocchi, Alberto Zaniboni · 2022 · Therapeutic Advances in Medical Oncology
  63. Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
    Weiwei Liu, Chaoqun Liu, Jia You, Zilin Chen, Cheng Qian, Wandie Lin, Lina Yu, Lele Ye, Liang Zhao, Rui Zhou · 2022 · Frontiers in Cell and Developmental Biology
  64. The Role of Non-Coding RNAs in Chromosomal Instability in Cancer
    Swati Mohapatra, Melanie Winkle, Anh N. Ton, Dien Nguyen, George A. Călin · 2022 · Journal of Pharmacology and Experimental Therapeutics
  65. Microsatellite instability and promoter hypermethylation in colorectal cancer in India
    Vishnubhotla Venkata Ravi Kanth, Sandeep Bhalsing, Mitnala Sasikala, G. V. Rao, R. Pradeep, Urmila Steffie Avanthi, Duvuru Nageshwar Reddy · 2014 · Tumor Biology
  66. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study
    Emily He, Nicholas John Hawkins, Gabriel Mak, Felicia T. Roncolato, David Goldstein, Winston Liauw, Philip R. Clingan, Melvin T.M. Chin, Robyn Lynne Ward · 2016 · The Oncologist
  67. Preclinical rationale for combination of crizotinib with mitomycin C for the treatment of advanced colorectal cancer
    Avital Lev, Safoora Deihimi, Elena I. Shagisultanova, Joanne Xiu, Amriti R. Lulla, David T. Dicker, Wafik S. El‐Deiry · 2017 · Cancer Biology & Therapy
  68. ILT4 in Colorectal Cancer Cells Induces Suppressive T Cell Contexture and Disease Progression
    Zijiang Yang, Aiqin Gao, Wenjing Shi, Jingnan Wang, Xianchao Zhang, Zhengyan Xu, Tingting Xu, Yan Zheng, Yuping Sun, Fei Yang · 2021 · OncoTargets and Therapy
  69. Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer
    Liu, Bojing, Polack, Meaghan, Coudray, Nicolas, Claudio Quiros, Adalberto, Sakellaropoulos, Theodore, Le, Hortense, Karimkhan, Afreen, Crobach, Augustinus S. L. P., van Krieken, J. Han J. M., Yuan, Ke et al. · 2025 · Nature Communications
  70. The Hallmarks of Predictive Oncology
    Akshat Singhal, Xiaoyu Zhao, Patrick Wall, Emily So, Guido Calderini, Alexander Partin, Natasha C. Koussa, Priyanka Vasanthakumari, Oleksandr Narykov, Yitan Zhu et al. · 2025 · Cancer Discovery
  71. Circulating miRNAs as liquid biopsy biomarkers for diagnosis in patients with colorectal cancer: a systematic review and meta-analysis
    Sydney Schwab, T. NONAKA · 2025 · Frontiers in Genetics
  72. Synergistic H&E and IHC image analysis by AI predicts cancer biomarkers and survival outcomes in colorectal and breast cancer
    Yating Cheng, Norsang Lama, Ming Chen, Eghbal Amidi, Mohammadreza Ramzanpour, Md. Samiur Rahman, Joanne Xiu, Anthony Helmstetter, Lauren R. Dickman, Jennifer R. Ribeiro et al. · 2025 · Communications Medicine
  73. Deepath-MSI: a clinic-ready deep learning model for microsatellite instability detection in colorectal cancer using whole-slide imaging
    Feng Xu, Wenjuan Yin, Qing Ye, Yayun Chi, Huer Wen, Yifeng Sun, Jin Zheng, Qifeng Wang, Qian Wang, Ming Zhao et al. · 2025 · npj Precision Oncology
  74. A pan-cancer analysis confirms PTPN11’s potential as a prognostic and immunological biomarker
    Yapeng Cao, Haixia Duan, Ailing Su, Liran Xu, Baochang Lai · 2022 · Aging
  75. Comprehensive analysis of transient receptor potential channels-related signature for prognosis, tumor immune microenvironment, and treatment response of colorectal cancer
    Lei Wang, Xingte Chen, Hejun Zhang, Liang Hong, Jianchao Wang, Lingdong Shao, Gang Chen, Junxin Wu · 2022 · Frontiers in Immunology
  76. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma
    Xia Liu, Xisheng Fang, Lin Lu, Guolong Liu · 2022 · Frontiers in Genetics
  77. Galectin-9 expression clinically associated with mature dendritic cells infiltration and T cell immune response in colorectal cancer
    Yang Wang, Ruizhi Zheng, Yanhui Zhang, Yuhong Guo, Zhenzhen Hui, Peijing Wang, Yan Sun · 2022 · BMC Cancer
  78. “Cold” colorectal cancer faces a bottleneck in immunotherapy
    Jialiang Liu, Ming Yang, Junge Bai, Zheng Liu, Xishan Wang · 2023 · World Journal of Gastrointestinal Oncology
  79. Comprehensive analysis of microbiota signature across 32 cancer types
    Xia Yang, Huimin An, Yongtao He, Guoxiang Fu, Zhinong Jiang · 2023 · Frontiers in Oncology
  80. Microsatellite instability: A potential game-changer in colorectal cancer diagnosis and treatment
    Rehanoddin Shaikh, Sankha Bhattacharya, Bhupendra Gopalbhai Prajapati · 2024 · Results in Chemistry
  81. Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer
    Solrun Melkorka Maggadottir, Svein Dueland, Nadia Mensali, Hanne Mari Hamre, Per Arne Andresen, Marit Renée Myhre, Hedvig Vidarsdotter Juul, Iris Bigalke, Marianne Lundby, Kirsti Hønnåshagen et al. · 2024 · Molecular Therapy
  82. Nilotinib boosts the efficacy of anti-PDL1 therapy in colorectal cancer by restoring the expression of MHC-I
    Haiyan Dong, Chuangyu Wen, Lu He, Jingdan Zhang, Nanlin Xiang, Liumei Liang, Limei Hu, Weiqian Li, Jiaqi Liu, Mengchen Shi et al. · 2024 · Journal of Translational Medicine
  83. PMS2 expression in epithelial ovarian cancer is posttranslationally regulated by Akt and essential for platinum-induced apoptosis
    Jinghui Jia, Zehua Wang, Jing Cai, Yuan Zhang · 2015 · Tumor Biology
  84. Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome
    Cristina Bozzao, Patrizia Lastella, Maurizio Ponz de Leòn, Monica Pedroni, Carmela Di Gregorio, Francesco Domenico D'Ovidio, Nicoletta Resta, Fernando Prete, Ginevra Guanti, Alessandro Stella · 2011 · Cancer
  85. Advances in the study of Lynch syndrome in China
    Junyu Lu, Jianqiu Sheng · 2015 · World Journal of Gastroenterology
  86. Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma
    Jacob J. Adashek, Meghan M. Salgia, Edwin M. Posadas, Robert A. Figlin, Jun Gong · 2019 · Clinical Genitourinary Cancer
  87. Rare DNA Mismatch Repair-Related Protein Loss in Patients with Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma and Their Response to Immunotherapy
    Jing Yu, Xi Zhang, Qiyue Huang, Sirui Tan, Xianze Xiong, Hongfeng Gou · 2021 · Cancer Management and Research
  88. Systematic review and meta-analysis of tumour microsatellite-instability status as a predictor of response to fluorouracil-based adjuvant chemotherapy in colorectal cancer
    Nikhil Aggarwal, Alberto Quaglia, Mark J.W. McPhail, Kevin John Monahan · 2021 · International Journal of Colorectal Disease
  89. Polyp Genetics
    Coen L. Klos, Sekhar Dharmarajan · 2016 · Clinics in Colon and Rectal Surgery
  90. Microsatellite instability assessment is instrumental for Predictive, Preventive and Personalised Medicine: status quo and outlook
    Jakub Styk, Zuzana Pös, Ondrej Pös, Ján Radvánszky, Evelina Hrckova Turnova, Gergely Buglyó, Daniela Klimová, Jaroslav Budiš, Vanda Repiská, Bálint Nagy et al. · 2023 · The EPMA Journal
  91. Microsatellite Instability in Sarcoma: Fact or Fiction?
    Michael J. Monument, Stephen L. Lessnick, Joshua David Schiffman, Rl. Tx. Randall · 2012 · ISRN Oncology
  92. Effects of propolis and gamma‐cyclodextrin on intestinal neoplasia in normal weight and obese mice
    Youngjin Cho, Linda S. Gutierrez, Michael Bordonaro, Daniel Russo, Frank Anzelmi, JAYDE T. HOOVEN-DAVIS, Carmine Cerra, Darina L. Lazarova · 2016 · Cancer Medicine
  93. Impact of age and mismatch repair status on survival in colorectal cancer
    Pan Li, Zhi‐Tao Xiao, Todd A. Braciak, Qingjian Ou, Gong Chen, Fuat S. Oduncu · 2017 · Cancer Medicine
  94. Germline mutation contribution to chromosomal instability
    Sock Hoai Chan, Joanne Yuen Yie Ngeow · 2017 · Endocrine Related Cancer
  95. The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
    Simon Ladefoged Rasmussen, Henrik Bygum Krarup, Kåre Andersson Gotschalck, Martin Berg Johansen, Mogens Tornby Stender, Inge Søkilde Pedersen, Poul Henning Madsen, Ole Thorlacius‐Ussing · 2018 · Oncotarget
  96. RNF43 frameshift mutations contribute to tumourigenesis in right-sided colon cancer
    Chong Lai, Wenjie Sun, Xiaosheng Wang, Xingyu Xu, Mengyuan Li, Dongdong Huang, Enping Xu, Maode Lai, Honghe Zhang · 2019 · Pathology - Research and Practice
  97. Microsatellite Instability and Life Style Factors in Sporadic Colorectal Cancer
    Nora Atef, Nelly Alieldin, Ghada M. Sherif, Iman Loay, Ahmed Mostafa Mahmoud, Ghada Mohamed · 2020 · Asian Pacific Journal of Cancer Prevention
  98. Genomic amplification of chromosome 20q13.33 is the early biomarker for the development of sporadic colorectal carcinoma
    Vo-Minh-Hoang Bui, Clément Mettling, Jonathan Jou, H. Sunny Sun · 2020 · BMC Medical Genomics
  99. Precision medicine for hereditary tumors in gynecologic malignancies
    Masayuki Sekine, Takayuki Enomoto · 2021 · Journal of obstetrics and gynaecology research
  100. Oral Cavity and Gastrointestinal Tract
    2012 · Elsevier eBooks